Concepedia

Jens Schroeder

JS

6

Publications

521

Citations

6

H-Index

2005

Active since

Affiliations

Bayer (Germany)(Current)

University of the Witwatersrand

Bayer (United States)

Jens Schroeder is an author at Bayer (Germany) specializing in medicine, immunology, and hematology.

Top concepts

Publications per year

2005–2020

6

Publications

6

Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS–SOS1 interaction

R.C. Hillig, Brice Sautier, Jens Schroeder et al. · Proceedings of the National Academy of Sciences · 2019 · 363 citations · Full text

High-Potential Human Mesenchymal Stem Cells

Claudia Lange, Jens Schroeder, Michael Lioznov et al. · Stem Cells and Development · 2005 · 47 citations

, , +12

Phase I, randomized, double‐blind, placebo‐controlled, single‐dose escalation study of the recombinant factor VIIa variant BAY 86‐6150 in hemophilia

Johnny Mahlangu, M Coetzee, Michael Laffan et al. · Journal of Thrombosis and Haemostasis · 2012 · 38 citations · Full text

, , +4

Computationally Empowered Workflow Identifies Novel Covalent Allosteric Binders for KRAS<sup>G12C</sup>

Jérémie Mortier, Anders Friberg, Volker Badock et al. · ChemMedChem · 2020 · 34 citations · Full text

<scp>TRUST</scp> trial: <scp>BAY</scp> 86‐6150 use in haemophilia with inhibitors and assessment for immunogenicity

Johnny Mahlangu, P. de Paz, Marion Hardtke et al. · Haemophilia · 2016 · 28 citations · Full text

Rows per page

1–5 of 6